Form 4 for ASH ASHLAND INC.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-03 · accession 0001127602-23-007198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-24 | 2023-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | M - OptEx | — | +5,052 | 3,197 | New | — |
| DM | 2023-02-24 | 2023-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | D - Sale to Iss | $105.31 | -5,052 | 440 | -92% | -$532.0K |
| DM | 2023-02-24 | 2023-02-03 | ASH | WANG XIAOLAN | SVP, Gen Mgr, Personal Care | M - OptEx | — | -5,052 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | M | A | 2,022 | — | 2,462 | D | — | — | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. |
| 2 | Common | Common Stock | 2023-02-03 | D | D | 2,022 | $105.31 | 440 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-03 | M | A | 273 | — | 713 | D | — | — | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. |
| 4 | Common | Common Stock | 2023-02-03 | D | D | 2,757 | $105.31 | 440 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-03 | M | A | 2,757 | — | 3,197 | D | — | — | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. |
| 6 | Common | Common Stock | 2023-02-03 | D | D | 273 | $105.31 | 440 | D | — | — | |
| 7 | Derivative | Restricted Stock Equivalents | 2023-02-03 | M | D | 2,757 | — | 0 | D | — · — to — | 2,757 Common Stock | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. (F4) Grant of cash-settled Restricted Stock Equivalents on February 3, 2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. One hundred percent of the shares awarded vested February 3, 2023. |
| 8 | Derivative | Restricted Stock Equivalents | 2023-02-03 | M | D | 2,022 | — | 0 | D | — · — to — | 2,022 Common Stock | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. (F2) Reporting Person's 2020-2022 Performance Stock Equivalents converted to time-based cash settled RSUs based on performance of the 2020-2022 LTIP Plan and vests three years from the original grant. |
| 9 | Derivative | Restricted Stock Equivalents | 2023-02-03 | M | D | 273 | — | 0 | D | — · — to — | 273 Common Stock | (F1) Each Restricted Stock Equivalent represents a right to receive one (1) share of Ashland Common Stock. The reporting person settled all of her Restricted Stock Equivalents for cash. (F3) Grant of cash-settled Restricted Stock Equivalents on February 3,2020, pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The s hares in this grant vest in three equal annual installments beginning one year from the date of the grant, provided that the Reporting Person remains in continuous employment with the Issuer. |